跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PADCEV 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PADCEV 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
PADCEV 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Astellas Pharma Europe B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 19, 2022
Approval ID
e23a40bc7dfee984
Company
Astellas Pharma Europe B.V.
Type
Standard
Approval Details
Approval Id
e23a40bc7dfee984
Drug Cima Aemps Name
PADCEV 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1211615001
Holder Company Name
Astellas Pharma Europe B.V.
Marketing Company Name
Astellas Pharma S.A.
Holder Company Detail Path
/organization/astellas-pharma-europe-b-v
Authorization Date
2022-05-19
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
20 MG
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Astellas Pharma Europe B.V.
Company Detail Path
/organization/astellas-pharma-europe-b-v
Company Information
Pharmaceutical Company Name
ASTELLAS PHARMA EUROPE B.V.
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE SERRANO, 110 - 4 IZQUIERDA
Active Ingredients
ENFORTUMAB VEDOTINA
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 19, 2022
Approval ID
e23a40bc7dfee984
Type
Standard
Back to CIMA-AEMPS Approvals